Violich Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
1,291
-355
-22% -$363K 0.17% 55
2026
Q1
$1.51M Buy
1,646
+200
+14% +$203K 0.18% 57
2025
Q4
$1.55M Buy
+1,446
New +$1.38M 0.17% 55

Other funds holding LLY

Violich Capital Management's LLY Position: Q2 2026 in Review

Violich Capital Management reduced its Eli Lilly (LLY) stake by 22% in Q2 2026, selling an estimated $363K and leaving 1,291 shares worth $1.55M. The position accounts for 0.17% of the portfolio, ranked #55.

Violich Capital Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.55M in Q4 2025. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Violich Capital Management held 1,291 shares of Eli Lilly worth $1.55M as of Q2 2026.
  • Violich Capital Management sold 355 Eli Lilly shares in Q2 2026, an estimated $363K.
  • Eli Lilly made up 0.17% of Violich Capital Management's portfolio in Q2 2026, its #55 holding.
  • Violich Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Violich Capital Management's Eli Lilly position peaked at $1.55M in Q4 2025.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.